News   |   Contact Us   |   Sign In   |   Join
News & Press: TPA News

Coronavirus Resources for Texas Pharmacists

Wednesday, March 11, 2020  
Share |

As the most accessible health care providers, Texas pharmacists should be prepared to field questions from patients about the novel coronavirus (COVID-19). They also need to be prepared to keep themselves safe and healthy. Learn about how to protect yourself, how to protect others, and treatment.

Pharmacies should implement infection control procedures and strategies to prevent person-to-person transmission of infection. Infection control procedures including administrative rules and engineering controls, environmental hygiene, correct work practices, and appropriate use of personal protective equipment (PPE) are all necessary to prevent infections from spreading during healthcare delivery. Frequent, effective handwashing, use of hand sanitizer and wiping frequently touched surfaces with an EPA-approved biocide should be common practices. Communicate to patients the importance of sick patients staying home, sending a friend to the pharmacy instead, or using the drive-through when possible.


View COVID-19 Recommendations for Texas Pharmacists

The Texas Pharmacy Association has compiled recommendations from the CDC and other sources to help pharmacists and their staff members practice in a safe and effective manner.

Click here to view recommendations regarding face coverings, social distancing, infection control, workforce protection, and more.


TPA is monitoring both state and federal agencies for information affecting Texas pharmacists and is in touch with Texas officials and agencies on concerns expressed by members. Following are additional resources to help pharmacy professionals:

Texas Department of State Health Services

COVID-19 in Texas

The Texas Department of State Health Services is providing regular updates about the coronavirus in the Lone Star State, including what to do if you are sick, COVID-19 testing, symptoms, and prevention.

DSHS has published a guidance for Texas consumers and pharmacists outlining strategies for managing pseudoephedrine purchases during the COVID-19 state of disaster.

Pharmacies utilizing an FDA-approved test for human diagnostic purposes of COVID-19 must submit to DSHS, as well as to the local health department, daily reports of all test results.

 Texas State Board of Pharmacy logo

Coronavirus Disease (COVID-19) Resources

The Texas State Board of Pharmacy has published resources for pharmacy professionals, including its authorization of emergency dispensing of prescription medications, medication limitations, sterile compounding guidance, and suspension of certain rules.

Centers for Disease Control and Prevention

Coronavirus Disease 2019

The Centers for Disease Control and Prevention has a wealth of information about what you should know, situation updates, and information tailored to specific populations.

COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations

Considerations for Pharmacies during the COVID-19 Pandemic

The CDC also answers frequently asked questions about the coronavirus for healthcare professionals such as pharmacists.

DSHS COVID-19 Symptom Chart

COVID-19 Communication Toolkit

The Texas Department of State Health Services has provided a toolkit including social media graphics to prevent the spread of COVID-19 as well as printable materials for display and/or distribution to communicate key information to the public.

FDA logo

Coronavirus Disease 2019 (COVID-19)

The Food and Drug Administration is working with U.S. Government partners, including CDC, and international partners to address the coronavirus disease 2019 (COVID-19) outbreak.

Drug Shortages

CLIA-Waived/Emergency Use Authorization

Pharmacists need to verify the test is deemed to be authorized for the CLIA-waived setting. There must be a "W" in the column titled "Authorized Settings" for any test, regardless of type, to be performed in a CLIA-waived laboratory.

Temporary Guidance for 503A Compounding

USP logo 

USP Compounding Resources for COVID-19

The USP Compounding Expert Committee developed the following informational resources that may be of assistance to pharmacists during this public health emergency:

CMS logo

Current Emergencies: Coronavirus

The Centers for Medicare and Medicaid Services is posting information and updates about its response to current emergencies including the coronavirus.

CMS Guidance for Medicare Part D Sponsors

Prescriber ID for Emergency Prescriptions

CLIA Application for Certification

HHS logo

Coronavirus (COVID-19)

The U.S. Department of Health & Human Services (HHS) and its federal partners are working together with state, local, tribal and territorial governments, public health officials, health care providers, researchers, private sector organizations and the public to execute a whole-of-America response to the COVID-19 pandemic to protect the health and safety of the American people.

HHS Authorizes Pharmacists to Order and Administer COVID-19 Vaccines to Persons Ages 3 or Older 

HHS Authorizes Pharmacists to Order and Administer Vaccines to Individuals Ages 3 through 18 

HHS Advisory Opinion Concludes Federal Law Permits Pharmacists to Order, Administer COVID-19 Tests

HHS Statements on Authorizing Licensed Pharmacists to Order and Administer COVID-19 Tests

 DEA logo

DEA COVID-19 Information

The U.S. Drug Enforcement Administration's Diversion Control Division has published important guidance concerning COVID-19 and the national drug supply, electronic prescribing of controlled substances, telemedicine, medicated assisted treatment, and other important federal and state information.

Early Prescription Refills

Guidance on Issuance of Oral Schedule II Prescriptions

World Health Organization logo

Coronavirus Disease (COVID-19) Pandemic

Q&A on Coronaviruses (COVID-19)

The World Health Organization has published a wealth of information, including regularly updated questions and answers about the coronavirus.

FIP logo

How Can Pharmacists Advise?

The International Pharmaceutical Federation (FIP) COVID-19 Information Hub includes a timeline and various guidance for pharmacists.

FIP has published Guidelines for Pharmacists and the Pharmacy Workforce.

major national pharmacy associations

Additional Information

Major national pharmacy associations have published their own guides for dealing with the coronavirus.

Membership Management Software Powered by YourMembership  ::  Legal